KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Return on Assets (2016 - 2025)

Historic Return on Assets for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to 0.0%.

  • Pfizer's Return on Assets changed 0.0% to 0.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.0% for FY2024, which is 0.0% changed from last year.
  • Per Pfizer's latest filing, its Return on Assets stood at 0.0% for Q3 2025, which was down 0.0% from 0.0% recorded in Q2 2025.
  • Pfizer's 5-year Return on Assets high stood at 0.01% for Q2 2021, and its period low was 0.0% during Q4 2021.
  • In the last 5 years, Pfizer's Return on Assets had a median value of 0.0% in 2022 and averaged 0.0%.
  • As far as peak fluctuations go, Pfizer's Return on Assets plummeted by -700bps in 2021, and later changed by 0bps in 2022.
  • Pfizer's Return on Assets (Quarter) stood at 0.0% in 2021, then skyrocketed by 102bps to 0.0% in 2022, then tumbled by -302bps to 0.0% in 2023, then soared by 127bps to 0.0% in 2024, then soared by 552bps to 0.0% in 2025.
  • Its Return on Assets stands at 0.0% for Q3 2025, versus 0.0% for Q2 2025 and 0.0% for Q1 2025.